- 07:26 AM Dubai debt worry ripples across assets
- 07:26 AM LSE stops trading for more than 3 hours
- 07:26 AM Surging food prices may prompt RBI action
- 07:26 AM Vedanta says Orissa bauxite mine will benefit poor
- 09:00 PM Ranbaxy launches new drug in the US: PharmAsiaNews
- 08:04 PM November 27: Events to watch out for
- 07:18 PM Govt deeply concerned about rising prices: Pranab ...
- 06:46 PM MFs net buy Rs 158 cr in equities on Nov 25
- 06:38 PM FIIs net buy Rs 65.20 cr in equities on Nov 25
- 06:27 PM Nirmal Bang's after market report



Lupin Limited, announced today that its subsidiary in the US, Lupin Pharmaceuticals, Inc. (LPI) has received final approval for the Company’s Abbreviated New Drug Application (ANDA) for Divalproex Sodium Delayed-Release Tablets, 125 mg, 250 mg and 500 mg from the U.S. Food and Drug Administration (USFDA). Commercial shipments of the product have already commenced.
Lupin’s Divalproex sodium delayed-release tablets are the AB-rated generic equivalent of Abbott Laboratories’ Depakote® tablets. Depakote had annual sales of approximately $803 million for the twelve months ended March 2008, based on IMS Health sales data.
With the approval of Divalproex Sodium Delayed-Release Tablets, the cumulative ANDA approvals of the Company stand at 31 (including 3 tentative approvals) with 34 pending approvals from the USFDA.
Sourced From: The Source
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Sensex ends 344 pts down; mkts see highest turnover ever
- Indian mkt to reach new highs in 2010: Roubini firm

- BMW unveils new 5 Series sedan
- Nov series ends with a whimper, experts see a quiet Dec

- Offer for Areva T&D unit 'competitive', says Alstom

- Ranbaxy launches new drug in the US: PharmAsiaNews
- November 27: Events to watch out for
- Mahindra Satyam hit by new charges; outlook uncertain
- Lanco Infra tying up funds for three power projects
Source: Business Line
- RIL units to get 20% of gas needs from D-6
Source: Business Line
- No need to ban cotton export, says Maran
Source: Business Line
- Karnataka hikes power tariff by 34.16 paise/unit
Source: Business Line










